Contour Neurovascular System™
Targets the neck of the aneurysm
Designed to treat a range of aneurysm morphologies including unruptured wide-necked bifurcation and bifurcation aneurysms:
Provides a combination of flow diversion at the neck of the aneurysm and flow disruption within the aneurysm sac;
Supports neo-intimal growth across mesh at neck and subsequent thrombosis of aneurysm;
Deployed with proven existing clinical techniques;
A single device occlusion that is re-sheathable & re-deployable;
Electrolytic method of detachment;
Strong IP portfolio - 3 patents issued and 3 patents pending;
No intra-arterial stabilizing component;
Reduces/eliminates need for dual anti-platelet therapy;
Simplified sizing approach compared to other intra-saccular devices (i.e. neck and widest diameter only).
What does it take to be a “big believer” in intrasaccular devices?
Tufail Patankar (UK) speaks about his personal experience with these effective tools, during the LINNC, Paris 2019 Congress.
How safe and effective are existing treatments for wide-necked bifurcation aneurysms?
Literature based objective performance criteria for safety and effectiveness
Journal of Neurointerventional Surgery, October 11, 2017
Meta-Analysis, Fiorella et al.
Description Outcome (1yr)
Wide Neck Bifurcation Aneurysm 2,795
Complete Occlusion 40%
Adequate Occlusion 70%
Conclusion: Conventional therapies for WNBAs are associated with relatively low rates of complete occlusion and peri-procedural complications are not uncommon. Newer therapies are needed for the treatment of these aneurysms. Until a ‘gold standard’ treatment strategy is established, these emerging technologies can be evaluated in comparison to the benchmark literature-derived OPC presented*.
Read or download the
Contour Launch Card
Indications for Use
The Contour Neurovascular System™ is indicated for the endovascular embolization of saccular intracranial aneurysms.
The Contour Neurovascular System™, Models CNS005-XX, CNS007-XX, CNS009XX and CNS011-XX, meet the essential requirements referred to in Article 3 of the MDD 93/42/EEC and are labelled with the CE Marking of conformity.
Products are not available for sale in the United States.